A detailed history of Yousif Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Yousif Capital Management, LLC holds 156,191 shares of GILD stock, worth $13.8 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
156,191
Previous 161,187 3.1%
Holding current value
$13.8 Million
Previous $11.8 Million 9.23%
% of portfolio
0.12%
Previous 0.13%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$63.15 - $72.88 $315,497 - $364,108
-4,996 Reduced 3.1%
156,191 $10.7 Million
Q1 2024

Apr 26, 2024

SELL
$71.58 - $87.29 $594,114 - $724,507
-8,300 Reduced 4.9%
161,187 $11.8 Million
Q4 2023

Feb 01, 2024

SELL
$73.27 - $83.09 $1.84 Million - $2.09 Million
-25,117 Reduced 12.91%
169,487 $13.7 Million
Q3 2023

Oct 30, 2023

SELL
$73.94 - $80.67 $2.88 Million - $3.14 Million
-38,956 Reduced 16.68%
194,604 $14.6 Million
Q2 2023

Aug 02, 2023

SELL
$76.01 - $86.7 $646,997 - $737,990
-8,512 Reduced 3.52%
233,560 $18 Million
Q1 2023

May 02, 2023

SELL
$77.31 - $88.08 $690,687 - $786,906
-8,934 Reduced 3.56%
242,072 $20.1 Million
Q4 2022

Jan 09, 2023

BUY
$62.32 - $89.47 $683,338 - $981,038
10,965 Added 4.57%
251,006 $0
Q3 2022

Nov 04, 2022

SELL
$59.54 - $68.01 $664,466 - $758,991
-11,160 Reduced 4.44%
240,041 $14.8 Million
Q2 2022

Aug 01, 2022

BUY
$57.72 - $65.01 $702,452 - $791,171
12,170 Added 5.09%
251,201 $15.5 Million
Q1 2022

May 12, 2022

BUY
$57.92 - $72.58 $385,399 - $482,947
6,654 Added 2.86%
239,031 $14.2 Million
Q4 2021

Jan 31, 2022

BUY
$64.88 - $73.64 $15.1 Million - $17.1 Million
232,377 New
232,377 $16.9 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.